About Us

MANAGEMENT TEAM

Olivier Delporte(*)
CEO

Olivier Delporte is an international executive with 20 years of sales, marketing and general management experiences, mostly in the medical devices industry.

Prior to Joining Miracor, he was Senior Vice President, Sales & Marketing, OUS at PneumRx (acquired by BTG in 2015) and, prior to that, the commercial operations of Tryton Medical in Europe, Middle East and Africa, as Vice President of Sales and marketing. Prior to Tryton Medical Management at Guidant and Abbott Vascular. Olivier has studied and worked in the US, France, Spain, and Belgium. He is a director of Endotoxins Therapeutics.

Olivier earned a Masters Degree in Business from the Université Catholique de Louvain, Belgium, and an MBA from the University of Chicago.

(*) represented by ODMC bvba, a management company

Bertrand G.

Bertrand Grimmonpré(*)
CFO

Bertrand Grimmonpré is a seasoned finance executive with 20+ years of experience general management & finance with international exposure for private and quoted groups.

Prior to joining Miracor in January 2017, Bertrand has hold CFO positions in various Medical Devices and Biotech companies like Novoste, Volcano Therapeutics, Celyad (Cardio³) and Medpole.

During the previous years, Bertrand has focused on restructuring, being CEO / CFO for Elo Touch Solutions, Prefarails, 4Decors, Heelys and WOW Technology. He started his career in the Hertz Lease Group, first as Accounting Manager for Ford Cegeac, the largest Ford Dealer in Belgium, then moving to European Finance Controllers, based in Portugal and UK, in charge of integrating newly acquired companies and financial / operational audits.

Bertrand holds a degree in taxation and accounting from the CBC in Brussels, completed with Corporate Finance (ISC St-Louis Brussels) and Interim Management (Vleerick School in Ghent) programs.

(*) represented by B & O Associates SPRL, a management company

 

Lars Schiemanck
CTO 

Lars has more than 20 years of experience in the medical device industry. After graduation from the Technical University of Eindhoven, the Netherlands where he studied (Medical) Electrical Engineering and Information Technology he started working as a lead embedded software engineer for a company (BTU Technology Unlimited) designing and building high tech computer controlled industrial machines.

Lars started his medical technology career at the Leiden University Laboratory for Clinical and Experimental Image Processing, where he was responsible for a group of researchers in the field of cardiovascular image processing.

This university research group as a whole commercialized into Medis Medical Imaging Systems BV, a company that has developed and commercialized leading quantitative products for angiography, computer tomography, intravascular ultrasound and magnetic resonance imaging (MRI) ordinarily for cardiology.

Lars has acted as Operational Manager for 5 years before taking on the role of VP of Corporate Technology and Support role. Medis before joining Miracor. He has been responsible for research, development, technical as well as commercial.

Dr. Roger Kessels
Clinical Director

Roger has 20 years of experience in the pharmaceutical and medical device industry working in clinical research as well as national and international sales & marketing positions.

His career in clinical research started in 2003 when he joined Medtronic as Senior Scientist and Clinical Research Manager at the Medtronic Bakken Research Institute in the Netherlands. He was involved in preclinical as well as clinical research as a scientist and later managed the research group.

Before joining Miracor, Roger worked for Vessix Vascular Inc. as their Clinical Research Manager. He was responsible for the clinical activities for the Vessix renal denervation technology in Europe. Vessix was acquired by Boston Scientific in November 2012.

Roger studied Biology at the University in Utrecht, the Netherlands, and he holds a PhD in Medicine from the University of Amsterdam, the Netherlands.

Kimberlie O’Connell
Vice President Regulatory, QA & US Operations

Kimberlie has more than 20 years of experience with a focus on cardiovascular therapies. She has held leadership roles in clinical, regulatory and quality for early stage, mid-stage and large organizations.

Prior to joining Miracor, Kim was Vice President of Clinical, Regulatory & Quality for Mitralign, Inc. where she was responsible for all clinical programs, achieving CE Mark and US Early Feasibility approvals for their mitral and tricuspid valve repair therapy.  Kim’s experience also includes 13 years with Medtronic where she held several roles in the Regulatory and Clinical Affairs organizations for the Coronary and Endovascular Therapies businesses.

Kim received a Bachelor of Science degree in Biotechnology from Worcester Polytechnic Institute, a Master’s degree in Pharmaceutical Law from Massachusetts College of Pharmacy and MBA from the Van Loan School of Management at Endicott College.

Jozef Tanczos
Vice President Clinical Affairs, Europe

Jozef has more than 15 years of experience in the pharmaceutical and medical device industry in clinical development across all phases for various IMPs, ATMPs and medical devices focus on early and translational medicine in cardiology, pulmonology, organ transplantation and regenerative medicine as well as several years of experience in animal research.

Before joining Miracor, Jozef was Director Medical Affairs and prior to that Director Clinical Affairs at PneumRx BTG where he where he played a key global role supporting clinical development and therapy adoption. Earlier in his career, Jozef worked with Xeltis developing an autologous pulmonary valve and cardiovascular conduits as well as with Roche and Astellas conducting clinical studies on various pharmaceutical products.

Jozef holds a MSc degree in  Biochemistry and Physiology at the Comenius University in Bratislava, Slovak Republic, and work as research fellow at Slovak Academy of Science conducting animal research on  ischemic precondition and myocardial regenerative pathways.